Compound Profile: Cenforce-25 Centurion Laboratories
Cenforce-25 is a sildenafil citrate preparation manufactured by Centurion Laboratories, containing 25mg of the active pharmaceutical ingredient per tablet. This formulation provides researchers with a standardised reference compound for investigating phosphodiesterase type 5 (PDE5) inhibition mechanisms in laboratory settings. Sildenafil citrate belongs to the class of selective PDE5 inhibitors, originally developed for cardiovascular research applications. The compound’s molecular structure enables specific binding to the PDE5 enzyme, making it valuable for studying cyclic guanosine monophosphate (cGMP) pathway modulation in cellular models. Researchers at Stroid UK Shop utilise this compound to examine endothelial function, smooth muscle relaxation pathways, and nitric oxide signalling cascades in controlled laboratory environments.
Laboratory Applications
In research contexts, Cenforce-25 enables scientists to investigate the pharmacokinetics and pharmacodynamics of PDE5 inhibition across various experimental models. The 25mg dosage provides an optimal concentration for dose-response studies and comparative analyses with other phosphodiesterase inhibitors. Cardiovascular researchers examine this compound’s effects on vascular smooth muscle cells, studying mechanisms of vasodilation and blood flow regulation in tissue cultures. Additionally, the formulation serves as a reference standard for analytical chemistry protocols, enabling researchers to develop and validate chromatographic methods for sildenafil quantification. Studies incorporating Cenforce-25 contribute to broader understanding of erectile dysfunction pathophysiology, pulmonary arterial hypertension mechanisms, and potential therapeutic applications in phosphodiesterase inhibitor research. Researchers also utilise this compound alongside selective androgen receptor modulators and research peptides in comprehensive endocrine and vascular studies.
Technical Specifications
| Active Ingredient | Sildenafil Citrate |
|---|---|
| Concentration | 25mg per tablet |
| Manufacturer | Centurion Laboratories |
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.7 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Purity | Verify with supplier |
Research Compliance
Cenforce-25 is manufactured exclusively for in-vitro research applications and laboratory analytical purposes. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must ensure compliance with institutional guidelines and applicable regulations when handling this compound. All studies involving Cenforce-25 should be conducted in appropriate laboratory settings with proper safety protocols and documentation procedures.
